Search

Start Over Keyword half-life

  • Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma

    Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma
    Authors:Samuel Stampfer, Emory UniversitySean Bujarski, Institute for Myeloma and Bone Cancer Research, West Hollywood CaliforniaMarissa-Skye Goldwater, Institute for Myeloma & Bone Cancer ResearchScott Jew, Institute for Myeloma and Bone Cancer Research, West Hollywood CaliforniaBernard Regidor, Berenson Cancer CenterHaiming Chen, Institute for Myeloma and Bone Cancer Research, West Hollywood CaliforniaNing Xu, Institute for Myeloma and Bone Cancer Research, West Hollywood CaliforniaMingjie Li, Institute for Myeloma and Bone Cancer Research, West Hollywood CaliforniaEddie Fung, Berenson Cancer CenterRegina Swift, Berenson Cancer CenterBethany Beatty, Berenson Cancer CenterShahrooz Eshaghian, Cedars-Sinai Medical CenterJames R Berenson, Institute for Myeloma and Bone Cancer Research, West Hollywood California
    Date:2023
    Publisher:Wiley Periodicals LLC.
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International